- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07275502
Prospective Development and Validation of an Objective Classification for Difficult Facemask Ventilation: the MASCAN Score
Prospective Development and Validation of an Objective Classification for Difficult Facemask Ventilation: the MASCAN Score - Secondary Analysis of the Prospective Observational MASCAN Study
Difficult facemask ventilation remains poorly classified. Existing definitions rely on expert opinion and subjective rating of surrogates. This lack of standardization has led to highly variable reported incidences and inconsistencies in clinical practice and research.
This secondary analysis of the prospective observational MASCAN study aims to develop and validate a data-driven objective classification system for difficult facemask ventilation and to determine its diagnostic performance and calibration. Facemask ventilation was facilitated after anaesthesia induction in all patients. An independent observer systematically assessed potential indicators for difficult facemask ventilation that serve as candidate predictor variables for the fitting of a diagnostic multivariable logistic regression model and simplified score to classify difficult facemask ventilation. Cross-validated LASSO regression will be used for variable selection. The area under the receiver operating characteristic curve (AUROC) and calibration curves will be used to quantify the diagnostic performance and calibration, and optimal decision thresholds will be defined.
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Hamburg, Germany, 20246
- Department of Anesthesiology, Center for Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients scheduling for ENT or OMS surgery in general anaesthesia, who require facemask ventilation and tracheal intubation after induction of anesthesia
- Patients aged at least 18 years
- Ability to understand the patient information and to personally sign and date the informed consent to participate in the study
- The patient is co-operative and available for the entire study
- Provided informed consent/patient representative
Exclusion Criteria:
- Pregnant or breastfeeding woman
- Rapid sequence induction or other contraindications for facemask ventilation
- Planned awake tracheal intubation
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difficult facemask ventilation
Time Frame: 1 hour
|
Alert documented in patients' health records by the airway operator following facemask ventilation (y/n)
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Airway-related adverse events
Time Frame: 1 hour
|
Laryngospasm, bronchospasm, larynx trauma, airway trauma, soft tissue trauma, oral bleeding, edema, dental damage, corticosteroid application, accidental esophageal intubation, aspiration, hypotension or hypoxia
|
1 hour
|
|
Impossible facemask ventilation
Time Frame: 1 hour
|
Observed impossible facemask ventilation after induction of anaesthesia (y/n)
|
1 hour
|
Collaborators and Investigators
Investigators
- Principal Investigator: Martin Petzoldt, MD, University Medical Centre Hamburg-Eppendorf
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2025-300636-WF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Airway Management
-
Bursa City HospitalEmre ULUSOYNot yet recruitingAirway Management | Difficult AirwayTurkey (Türkiye)
-
Royal Hospital, OmanNot yet recruitingDifficult Airway | Obesity Difficult Airway Airway Management
-
Kutahya Health Sciences UniversityCompletedAirway Management | Difficult Airway | Difficult Airway IntubationTurkey (Türkiye)
-
NHS TaysideTerminated
-
Akdeniz University HospitalCompletedAirway Management | Difficult Airway | Obstetric AnesthesiaTurkey (Türkiye)
-
Diskapi Teaching and Research HospitalNot yet recruitingAirway ManagementTurkey (Türkiye)
-
Thomas RivaThe Hospital for Sick Children; Children's Hospital of Philadelphia; Charite... and other collaboratorsRecruitingAirway ManagementUnited States, Australia, Switzerland, Italy, Canada, Germany, Brazil
-
Peking Union Medical College HospitalNot yet recruiting
-
University of MalayaActive, not recruiting
-
Akdeniz UniversityCompletedAirway ManagementTurkey (Türkiye)